Surgery Partners (SGRY) Stock Price, News & Analysis

+0.21 (+0.88%)
(As of 04/22/2024 ET)
Today's Range
50-Day Range
52-Week Range
605,114 shs
Average Volume
898,513 shs
Market Capitalization
$3.04 billion
P/E Ratio
Dividend Yield
Price Target

Surgery Partners MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.88 Rating Score
81.5% Upside
$43.63 Price Target
Short Interest
11.33% of Float Sold Short
Dividend Strength
News Sentiment
0.00mentions of Surgery Partners in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$608,352 Sold Last Quarter
Proj. Earnings Growth
From $0.78 to $1.06 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.30 out of 5 stars

Medical Sector

728th out of 909 stocks

General Medical & Surgical Hospitals Industry

5th out of 5 stocks

SGRY stock logo

About Surgery Partners Stock (NASDAQ:SGRY)

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

SGRY Stock Price History

SGRY Stock News Headlines

Global crypto currency reset (41 major banks signed up)
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
Surgery Partners (NASDAQ:SGRY) Trading 2.6% Higher
Global crypto currency reset (41 major banks signed up)
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
Surgery Partners initiated with neutral view at Barclays
SGRY Mar 2024 30.000 put
Company News for Feb 27, 2024
Q4 2023 Surgery Partners Inc Earnings Call
Surgery Partners: Q4 Earnings Snapshot
SGRY Apr 2024 50.000 call
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

General medical & surgical hospitals
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
8 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$2.74 billion
Cash Flow
$1.81 per share
Book Value
$23.99 per share


Free Float
Market Cap
$3.04 billion
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

SGRY Stock Analysis - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SGRY shares.
View SGRY analyst ratings
or view top-rated stocks.

What is Surgery Partners' stock price target for 2024?

8 brokerages have issued 12 month target prices for Surgery Partners' stock. Their SGRY share price targets range from $35.00 to $50.00. On average, they predict the company's share price to reach $43.63 in the next twelve months. This suggests a possible upside of 81.5% from the stock's current price.
View analysts price targets for SGRY
or view top-rated stocks among Wall Street analysts.

How have SGRY shares performed in 2024?

Surgery Partners' stock was trading at $31.99 at the start of the year. Since then, SGRY stock has decreased by 24.9% and is now trading at $24.04.
View the best growth stocks for 2024 here

When is Surgery Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our SGRY earnings forecast

How can I listen to Surgery Partners' earnings call?

Surgery Partners will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13746011".

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings data on Monday, February, 26th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. The firm earned $735.40 million during the quarter, compared to analyst estimates of $741.93 million. Surgery Partners had a positive trailing twelve-month return on equity of 3.65% and a negative net margin of 0.43%. The company's revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.22 EPS.

What ETFs hold Surgery Partners' stock?
What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.0 billion-, compared to the consensus revenue estimate of $3.0 billion.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?
Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.02%) and Cannon Global Investment Management LLC (0.02%). Insiders that own company stock include Andrew T Kaplan, Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Harrison R Bane, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SGRY) was last updated on 4/23/2024 by Staff

From Our Partners